Related Experiment Videos
Long-term survival after liver transplantation
F C Ryckman1, M H Alonso, J C Bucuvalas
1Children's Hospital Medical Center, University of Cincinnati, OH 45229, USA.
Journal of Pediatric Surgery
|June 8, 1999
Summary
Late deaths after liver transplantation are primarily caused by sepsis and immunosuppression complications. Adherence to medical regimens and optimal allograft function are crucial for preventing late mortality in pediatric liver transplant recipients.
Area of Science:
- Hepatology
- Transplant Surgery
- Immunology
Background:
- Liver transplantation (LT) is a high-risk procedure with significant early mortality due to technical issues and pre-existing conditions.
- Late deaths after LT, though less common, pose a distinct challenge to long-term patient survival.
- This study investigates factors contributing to mortality beyond the initial postoperative period.
Purpose of the Study:
- To identify the causes and contributing factors of late mortality in liver transplant recipients.
- To determine if early prognostic indicators predict long-term survival.
- To inform strategies for improving long-term outcomes in liver transplant patients.
Main Methods:
- Retrospective review of 150 liver transplant patients over an 11-year period.
- Analysis of mortality data, focusing on the 15 patients (11%) who died late (after 3 months post-transplant).
- Categorization of causes of death, including sepsis, post-transplant complications, and lymphoproliferative disease.
Main Results:
- Sepsis was the leading cause of late death, accounting for 73% of cases, often complicating retransplantation or occurring in immunocompromised patients.
- Other causes included late-presenting complications (bile leaks, abscesses, intestinal obstruction), Pneumocystis carinii pneumonia, and multiple organ system failure.
- Lymphoproliferative disease (LPD) caused 20% of late deaths; only three deaths were directly related to the primary liver disease.
Conclusions:
- Long-term survival after LT is significantly impacted by sepsis and complications arising from immunosuppression.
- Early mortality predictors (UNOS status, age, primary diagnosis, technical issues) do not reliably predict late deaths.
- In pediatric recipients, adherence to medical regimens and good initial allograft function are key; late infections, particularly EBV, are major causes of mortality, suggesting a need for optimized immunosuppression strategies.